1,779 reports of this reaction
7.1% of all GLYCERIN, LIDOCAINE reports
#4 most reported adverse reaction
DRUG ADMINISTRATION ERROR is the #4 most commonly reported adverse reaction for GLYCERIN, LIDOCAINE, manufactured by Haleon US Holdings LLC. There are 1,779 FDA adverse event reports linking GLYCERIN, LIDOCAINE to DRUG ADMINISTRATION ERROR. This represents approximately 7.1% of all 25,225 adverse event reports for this drug.
Patients taking GLYCERIN, LIDOCAINE who experience drug administration error should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG ADMINISTRATION ERROR is moderately reported among GLYCERIN, LIDOCAINE users, representing a notable but not dominant share of adverse events.
In addition to drug administration error, the following adverse reactions have been reported for GLYCERIN, LIDOCAINE:
The following drugs have also been linked to drug administration error in FDA adverse event reports:
DRUG ADMINISTRATION ERROR has been reported as an adverse event in 1,779 FDA reports for GLYCERIN, LIDOCAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG ADMINISTRATION ERROR accounts for approximately 7.1% of all adverse event reports for GLYCERIN, LIDOCAINE, making it a notable side effect.
If you experience drug administration error while taking GLYCERIN, LIDOCAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.